ФУНКЦИОНАЛЬНО-МЕТАБОЛИЧЕСКИЕ ОСОБЕННОСТИ ФАГОЦИТОВ КРОВИ ПРИ РАЗНЫХ ФОРМАХ ТУБЕРКУЛЕЗНОГО ВОСПАЛИТЕЛЬНОГО ПРОЦЕССА ЛЕГКИХ
https://doi.org/10.15789/1563-0625-2016-1-21-32
Аннотация
Ключевые слова
Об авторах
О. В. БердюгинаРоссия
д.б.н., ведущий научный сотрудник, лаборатория диагностических и экспериментальных методов исследования,
620039, г. Екатеринбург, ул. XXII партсъезда, 50
А. В. Ершова
Россия
научный сотрудник, лаборатория диагностических и экспериментальных методов исследования,
620039, г. Екатеринбург, ул. XXII партсъезда, 50
Список литературы
1. Мордык А.В., Батищева Т.Л., Брюханова Н.С., Пузырева Л.В. Влияние иммунологических нарушений на исход впервые выявленного инфильтративного туберкулеза у социально сохранных пациентов // Инфекция и иммунитет, 2014. Т. 4, №4. С. 353-358.[Mordyk A.V., Batishcheva T.L., Bryukhanova N.S., Puzyreva L.V. Influence of immunological disorders on an outcome for the first time diadnosed infiltrative tuberculosis in socially safe patients. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2014, Vol. 4, no. 4, pp. 353-358. doi: 10.15789/2220-7619-2014-4-353-358 (In Russ.)]
2. Ameglio F., Casarini M., Capoluongo E., Mattia P., Puglisi G., Giosuè S. Post-treatment changes of six cytokines in active pulmonary tuberculosis: differences between patients with stable or increased fibrosis. Int. J. Tuberc. Lung. Dis., 2005, Vol. 9, no. 1, pp. 98-104.
3. Ariga H., Harada N. Evolution of IGRA researches. Kekkaku, 2008, Vol. 83, no. 9, pp. 641-652.
4. Bell L.C.K., Breen R., Miller R.F., Noursadeghi M., Lipman M. Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis. International J. of Infectious Diseases, 2015, Vol. 32, pp. 39-45.
5. Dorhoi A., Kaufmann S.H. Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis. Semin. Immunopathol., 2015, Vol. 5, pp. 1-14.
6. Duque C., Arroyo L., Ortega H., Montufar F., Ortiz B., Rojas M., Barrera L.F. Different responses of human mononuclear phagocyte populations to Mycobacterium tuberculosis. J. Tuberculosis, 2014, Vol. 94, Issue 2, pp. 111-122.
7. Ferraz J.C., Melo F.B.S., Albuquerque M.F.P.M., Montenegro S.M.L., Abath F.G.C. Immune factors and immunoregulation in tuberculosis. Braz. J. Med. Biol. Res., 2006, Vol. 39, no. 11, pp. 1387-1397.
8. Flannagan R.S., Cosío G., Grinstein S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nature Reviews Microbiology, 2009, no. 7, pp. 355-366.
9. Hunter R.L. Pathology of post primary tuberculosis of the lung: an illustrated critical review. Tuberculosis (Edinburgh, Scotland), 2011, Vol. 91, no. 6, pp. 497-509.
10. Miranda M.S., Breiman A., Allain S., Deknuydt F., Altare F. The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria? Clinical and Developmental Immunology, 2012, Vol. 2012, pp. 1-14.
11. Ramachandra L., Smialek J. L., Shank S. S., Convery M., Boom W. H., Harding C. V. Phagosomal processing of Mycobacterium tuberculosis antigen 85b is modulated independently of mycobacterial viability and phagosome maturation. Infection and Immunity, 2005, Vol. 73, no. 2, pp. 1097-1105.
12. Sakamoto K. The Pathology of Mycobacterium tuberculosis infection. Veterinary Pathology, 2012, Vol. 49, no. 3, pp. 423-439.
13. Sakharova I.I., Ariél B.M., Skvortsova I.A., Knoring B.E., Vishnevski B.I., Aleshina G.M., Kokriakov V.N. Immunological parameters and mycobacterial biological properties in infiltrative pulmonary tuberculosis. Probl. Tuberk. Bolezn. Legk., 2005, no. 11, pp. 14-18.
14. Sharma S.K., Mohan A., Sharma A. Challenges in the diagnosis and treatment of miliary tuberculosis. Indian J. Med. Res, 2012, Vol. 135, no. 5, pp.703-730.
15. Tuberculosis / M. Monir Madkour, ed. Germany: Springer Science & Business Media, 2004. 930 p.
16. Ulrichs T., Kosmiadi G.A., Jörg S., Pradl L., Titukhina M., Mishenko V., Gushina N., Kaufmann S.H.E. Differential organization of the local immune response in patients with active cavitary tuberculosis or with nonprogressive tuberculoma. J. Infect. Dis., 2005, Vol. 192, no. 1, pp. 89-97.
17. Van Crevel R., Ottenhoff T.H.M., Van der Meer J.W.M. Innate Immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev., 2002, Vol. 15, no. 2, pp. 294-309.
18. Vergne I., Chua J., Singh S.B., Deretic V. Cell biology of Mycobacterium tuberculosis phagosome. Annu Rev. Cell Dev. Biol., 2004, Vol. 20, pp. 367-394.
19. Walzl G., Ronacher K., Hanekom W., Scriba T.J., Zumla A. Immunological biomarkers of tuberculosis. Nature Reviews Immunology, 2011, Vol. 11, pp. 343-354.
20. Wang Q, Liu S., Tang Y., Liu Q., Yao Y. MPT64 Protein from Mycobacterium tuberculosis inhibits apoptosis of macrophages through NF-kB-miRNA21-Bcl-2 pathway. J. Plos, 2014, Vol. 9, Issue 7, pp. 1-8.
Рецензия
Для цитирования:
Бердюгина О.В., Ершова А.В. ФУНКЦИОНАЛЬНО-МЕТАБОЛИЧЕСКИЕ ОСОБЕННОСТИ ФАГОЦИТОВ КРОВИ ПРИ РАЗНЫХ ФОРМАХ ТУБЕРКУЛЕЗНОГО ВОСПАЛИТЕЛЬНОГО ПРОЦЕССА ЛЕГКИХ. Медицинская иммунология. 2016;18(1):21-32. https://doi.org/10.15789/1563-0625-2016-1-21-32
For citation:
Berdyugina O.V., Yershova A.V. FUNCTIONAL AND METABOLIC FEATURES OF BLOOD PHAGOCYTES AT DIFFERENT FORMS OF TUBERCULAR INFLAMMATORY PROCESS OF LUNGS. Medical Immunology (Russia). 2016;18(1):21-32. (In Russ.) https://doi.org/10.15789/1563-0625-2016-1-21-32